Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pradines, B.
Right arrow Articles by Parzy, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pradines, B.
Right arrow Articles by Parzy, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 179-184
© 2001 The British Society for Antimicrobial Chemotherapy

Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum

B. Pradinesa,*, T. Fusaia, W. Dariesa, V. Lalogeb, C. Rogiera, P. Milletc, E. Panconid, M. Kombilae and D. Parzya

a Unité de Parasitologie, Institut de Médecine Tropicale du Service de Santé des Armées, Bd C. Livon, Parc Le Pharo, BP 46, 13998 Marseille Armées, France; b Service Médical, 6ième Bataillon d'Infanterie de Marine, Libreville, Gabon; c Centre Labusquière, Université de Bordeaux II, Bordeaux, France; d Institut de Recherche Pierre Fabre, Labège Innopole, France; e Département de Parasitologie-Mycologie-Médecine Tropicale, Faculté de Médecine et des Sciences de la Santé, Libreville, Gabon

The in vitro activities of ferrochloroquine, chloroquine, quinine, mefloquine, halofantrine, amodiaquine, primaquine, atovaquone and artesunate were evaluated against Plasmodium falciparum isolates from children with uncomplicated malaria from Libreville (Gabon), using an isotopic, micro, drug susceptibility test. The IC50 values for ferrochloroquine were in the range 0.43–30.9 nM and the geometric mean IC50 for the 103 isolates was 10.8 nM (95% CI 8.6–13.5 nM), while the geometric means for chloroquine, quinine, mefloquine, amodiaquine and primaquine were 370 nM, 341 nM, 8.3 nM, 18.1 nM and 7.6 µM, respectively. Ferrochloroquine was active against P. falciparum isolates, 95% of which showed in vitro resistance to chloroquine. Weak positive significant correlations were observed between the responses to ferrochloroquine and that to chloroquine, amodiaquine and quinine, but too low to suggest cross-resistance. There was no significant correlation between the response to ferrochloroquine and those to mefloquine, halofantrine, primaquine, atovaquone or artesunate. Ferrochloroquine may be an important alternative drug for the treatment of chloroquine-resistant malaria.

* Corresponding author. Tel: +33-4-91-15-01-10; Fax: +33-4-91-15-01-64; E-mail: bruno.pradines{at}free.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
M. Henry, S. Briolant, A. Fontaine, J. Mosnier, E. Baret, R. Amalvict, T. Fusai, L. Fraisse, C. Rogier, and B. Pradines
In Vitro Activity of Ferroquine Is Independent of Polymorphisms in Transport Protein Genes Implicated in Quinoline Resistance in Plasmodium falciparum
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2755 - 2759.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Ramharter, F. M. Kurth, S. Belard, M. K. Bouyou-Akotet, M. M. Mamfoumbi, S. T. Agnandji, M. A. Missinou, A. A. Adegnika, S. Issifou, N. Cambon, et al.
Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon
J. Antimicrob. Chemother., November 1, 2007; 60(5): 1091 - 1096.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. KREIDENWEISS, P. G. KREMSNER, K. DIETZ, and B. MORDMULLER
IN VITRO ACTIVITY OF FERROQUINE (SAR97193) IS INDEPENDENT OF CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUM
Am J Trop Med Hyg, December 1, 2006; 75(6): 1178 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
W. Daher, L. Pelinski, S. Klieber, F. Sadoun, V. Meunier, M. Bourrie, C. Biot, F. Guillou, G. Fabre, J. Brocard, et al.
IN VITRO METABOLISM OF FERROQUINE (SSR97193) IN ANIMAL AND HUMAN HEPATIC MODELS AND ANTIMALARIAL ACTIVITY OF MAJOR METABOLITES ON PLASMODIUM FALCIPARUM
Drug Metab. Dispos., April 1, 2006; 34(4): 667 - 682.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. Atteke, J. M. M. Ndong, A. Aubouy, L. Maciejewski, J. Brocard, J. Lebibi, and P. Deloron
In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooue region of Gabon
J. Antimicrob. Chemother., April 1, 2003; 51(4): 1021 - 1024.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.